Is Isotretinoin safe?
Isotretinoin
Isotretinoin (Accutane, Absorica, Roaccutane) is the most effective treatment for severe acne. Dry skin and lips are near-universal and blood fats often rise. Its defining risk is severe birth defects, managed through the US iPLEDGE programme, and regulators also require checks for mood changes and sexual side effects.
- Brands
- Absorica, Absorica LD, Zenatane and generics (US); Roaccutane (UK); original Accutane discontinued
- Dose (US generic label)
- 0.5 to 1 mg/kg a day in two doses for 15 to 20 weeks; up to 2 mg/kg a day for very severe acne in adults
- Boxed warning
- Life-threatening birth defects; only available through the iPLEDGE REMS
- Contraception (if you can get pregnant)
- Two forms at once, from 1 month before to 1 month after treatment
- High triglycerides
- About 25% of patients (US label)
- Supply rules (US)
- Up to 30 days at a time, no refills
- Controlled substance
- No
- On the market
- US since May 1982
How the score breaks down
The overall score is the weighted average of these factors. Scoring rules
Serious side effects30% of score
45 out of 100, WeakAny exposure in pregnancy carries an extremely high risk of major birth defects (Boxed warningThe strongest safety warning the US FDA puts on a medicine's label, printed inside a black border at the top.More in the glossary). The label also warns of depression and rarely suicide, raised triglycerides (25%), pancreatitis, bowel inflammation, severe skin reactions and sexual dysfunction that may persist.
Overdose margin20% of score
85 out of 100, ExcellentOverdose has caused vomiting, flushing, cracked lips, stomach pain, headache and dizziness, which resolved quickly without lasting effects (US label). Pregnancy must be checked after an overdose.
Interactions15% of score
80 out of 100, GoodFew, but two matter. Vitamin A supplements add to its toxicity, and tetracycline antibiotics such as doxycycline and minocycline raise the risk of raised pressure in the skull. It did not change levels of a standard combined pill.
Dependence and misuse15% of score
95 out of 100, ExcellentNot a Controlled substanceA medicine or drug that the law restricts because it can be misused or cause dependence. Countries group them into schedules or classes.More in the glossary, with no misuse potential or withdrawal.
Regulatory warnings10% of score
15 out of 100, PoorBoxed warningThe strongest safety warning the US FDA puts on a medicine's label, printed inside a black border at the top.More in the glossary and one of the strictest US access programmes (iPLEDGE REMS), with pregnancy tests before each 30-day supply. The UK added mental health and sexual function checks in 2023 and updated its prescribing rules in January 2026.
Track record10% of score
90 out of 100, ExcellentApproved in the US as Accutane in May 1982, with over four decades of use and large studies, including a 2024 meta-analysis of 25 studies and about 1.6 million people on psychiatric risk.
Is isotretinoin safe?
For people with severe acne who use it under the rules, mostly yes, but it is one of the most tightly controlled medicines in routine use. Isotretinoin, first sold in the US as Accutane in 1982 and in the UK as Roaccutane, clears acne that has not responded to antibiotics and often keeps it away. A typical course lasts 15 to 20 weeks.
Its central risk is pregnancy. Any amount, even for a short time, carries what the US label calls an "extremely high risk" of life-threatening birth defects of the face, ears, eyes, heart and brain. That is why it has a Boxed warningThe strongest safety warning the US FDA puts on a medicine's label, printed inside a black border at the top.More in the glossary and is only available through the iPLEDGE programme. We score it 67, below montelukast (78) and finasteride (81), two other medicines watched for mood or sexual effects, because the pregnancy risk and side-effect list are heavier.
The pregnancy rules
In the US, everyone who takes isotretinoin is registered in iPLEDGE, and so are prescribers and pharmacies. For people who can get pregnant, the label requires:
- Two forms of contraception at the same time, at least one of them a primary method, from 1 month before starting until 1 month after the last dose (or a commitment to abstinence).
- A screening and a confirmatory negative pregnancy test before the first prescription.
- A test before every prescription, at the end of the course, and 1 month after stopping.
- Collecting each prescription within 7 days of the test; pharmacies supply at most 30 days and no refills.
The FDA approved changes in February 2026 that let prescribers allow home pregnancy tests during and after treatment, with the first tests still done in a clinic. The start date has been moved to 15 November 2026. Earlier changes removed the 19-day lockout for people who missed their window.
Everyone, regardless of sex, must not share capsules or donate blood during treatment and for 1 month after.
Mood, mental health and sexual side effects
The label warns of depression, psychosis, aggression and, rarely, suicidal thoughts, suicide attempts and suicide. Evidence on cause is mixed. A 2024 meta-analysis in JAMA Dermatology, pooling 25 studies with about 1.6 million people, found the one-year risk of suicide attempts, suicidal thoughts and self-harm was each below 0.5%. Users were not more likely to attempt suicide than non-users at two years. Depression was reported by 3.83% in the first year.
UK regulators took a cautious line anyway. In October 2023 the MHRA required mental health and sexual function checks before and during treatment and two prescribers for under-18s. In January 2026 it dropped the second-prescriber rule but kept the checks, added a new risk form and patient video, and started a national audit. Sexual dysfunction (erectile problems, low libido, vaginal dryness) is on the US label as something that may continue after treatment.
The physical side effects
Dry lips, skin, eyes and nose affect almost everyone, and lip inflammation is dose-related. Beyond that, the label lists:
- Raised triglycerides in about 25% of patients, which is why fasting lipid tests are done before and during treatment.
- Muscle and joint pain; CPK, a muscle enzyme, was markedly raised in about 24% of people in one trial, often after hard exercise.
- Raised pressure in the skull (headache, vision changes), especially with tetracycline antibiotics.
- Rarer serious problems: pancreatitis, hepatitis, inflammatory bowel disease, severe skin reactions (SJS and TEN), hearing loss and reduced night vision.
Interactions
The list is short. Avoid vitamin A supplements, including high-dose multivitamins, because isotretinoin is a form of vitamin A; see our vitamin A page for the upper limits. Avoid tetracycline antibiotics such as doxycycline and minocycline, which many people take for acne before switching. In a study with a standard combined pill, isotretinoin did not change hormone levels, but whether it affects other contraceptives is not known.
How to take it safely
Take the capsules with a full glass of liquid, whole, in two doses a day. Absorica LD is a different formulation and is not interchangeable milligram for milligram. Use lip balm and eye drops, avoid waxing, dermabrasion and laser treatments during the course and for at least 6 months after (the label warns of scarring), and use sunscreen. If a dose is missed, skip it rather than doubling up. If your mood changes or you get severe stomach pain, headache with vision changes or bloody diarrhoea, stop and contact your prescriber straight away. Talk to your doctor or pharmacist about any other medicine or supplement before starting.
How we scored it
Track record (90), dependence (95) and Overdose marginHow far a normal dose is from a harmful one. A wide margin means an accidental extra dose is unlikely to cause serious harm.More in the glossary (85) are strong. Regulatory warnings (15) is the weakest factor, reflecting the Boxed warningThe strongest safety warning the US FDA puts on a medicine's label, printed inside a black border at the top.More in the glossary, iPLEDGE and the UK measures. Serious side effects (45) is held down by the birth defect risk and a long list of uncommon but serious effects.
Questions people ask
Does Accutane cause depression or suicide?
The label warns of depression, psychosis and, rarely, suicidal thoughts and suicide. A 2024 meta-analysis found the one-year risk of suicide attempts and self-harm was each below 0.5%, and users were not more likely to attempt suicide than people who did not take it. Severe acne itself affects mood, so the link is hard to separate. Tell your prescriber about any history of mental illness, and stop and call them if mood changes.
Why do I need pregnancy tests on isotretinoin?
Because any amount taken in pregnancy carries an extremely high risk of severe birth defects. In the US, people who can get pregnant need two negative tests before starting, a test before each monthly prescription, and tests at the end of treatment and a month later. They must use two forms of contraception from a month before to a month after treatment.
Can I drink alcohol on isotretinoin?
The label does not ban alcohol, but isotretinoin raises triglycerides and can affect the liver, and the label says to wait 36 hours after drinking before a fasting lipid test. Ask your prescriber how much is reasonable for you.
Do isotretinoin side effects go away after stopping?
Most do, including dry skin, lips and eyes. The label notes that some effects can last after treatment, including sexual dysfunction and, in some cases, hair loss. Report anything that persists to your doctor.
Can men take isotretinoin while trying for a baby?
The label does not ban this, but men must not share their capsules and must not donate blood during treatment and for 1 month after. After an overdose, the label advises men to use a condom with a partner who could get pregnant for 1 month. Talk to your prescriber if you are planning a pregnancy.
Sources
- 1.Isotretinoin capsules prescribing information (opens in a new tab) · DailyMed / Actavis Pharma, 2026
- 2.iPLEDGE Risk Evaluation and Mitigation Strategy (REMS) (opens in a new tab) · US Food and Drug Administration, 2026
- 3.Isotretinoin – changes to prescribing guidance and additional risk minimisation measures (opens in a new tab) · MHRA Drug Safety Update, 2026
- 4.Isotretinoin (Roaccutane): introduction of new safety measures, including additional oversight of the initiation of treatment for patients under 18 years of age (opens in a new tab) · MHRA Drug Safety Update, 2023
- 5.Risk of suicide and psychiatric disorders among isotretinoin users: a meta-analysis (opens in a new tab) · JAMA Dermatology, 2024